logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
09/07/2025
The Australia S&P/ASX 200 index closed down 0.6% at 8,538.60 points.
Latest
2 m ago
China Everbright Source Group (08128.HK) repurchased 960,000 shares for HK$38,400 on July 9.
3 m ago
Yinghantong: Shareholder Defengjie reduces holdings of company shares by not more than 2.21%
4 m ago
Changlan Technology (002879.SZ) won the bid for the 97.16 million yuan cable accessory framework project.
4 m ago
Barclays: High tariffs may lead to higher drug prices and shortages in the United States, with consumers bearing the brunt.
4 m ago
Barclays analysts pointed out in a research report that the US plan to impose tariffs of up to 200% on drugs may have a significant impact on the pharmaceutical industry in the long run. Such high tariffs will raise production costs, squeeze profit margins, and may lead to disruptions in the supply chain. This is likely to cause drug shortages and ultimately result in higher drug prices for American consumers. However, the government may provide companies with a transition period of up to a year and a half to adjust before the tariffs are officially implemented, which could be a positive factor for the industry.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.